Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

被引:111
作者
Tsutamoto, T [1 ]
Wada, A [1 ]
Matsumoto, T [1 ]
Maeda, K [1 ]
Mabuchi, N [1 ]
Hayashi, M [1 ]
Tsutsui, T [1 ]
Ohnishi, M [1 ]
Sawaki, M [1 ]
Fujii, M [1 ]
Matsumoto, T [1 ]
Yamamoto, T [1 ]
Horie, H [1 ]
Sugimoto, Y [1 ]
Kinoshita, M [1 ]
机构
[1] Shiga Univ Med Sci, Dept Internal Med 1, Otsu, Shiga 5202192, Japan
关键词
D O I
10.1016/S0735-1097(01)01299-2
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives This study evaluated oxidative stress in the failing ventricle in patients with dilated cardiomyopathy (DCM). Background Oxidative stress appears to increase in the failing myocardium and may contribute to ventricular dysfunction in patients with DCM. Tumor necrosis factor-alpha (TNF-alpha), which is expressed in the failing heart, may stimulate oxidative stress. Methods We measured plasma oxidized low density lipoprotein (oxLDL) by sandwich enzyme-linked immunosorbent assay using specific antibodies against oxLDL in the aortic root (AO) and the coronary sinus (CS) in control subjects (n = 8) and in 22 patients with DCM and mild congestive heart failure. We also measured the plasma levels of TNF-alpha and angiotensin Results There was no difference in oxLDL between the AO and CS in control subjects. In contrast, plasma oxLDL was significantly higher in the CS than the AO in patients with DCM, suggesting that the transcardiac gradient of oxLDL reflects oxidative stress in the failing heart in these patients. Plasma TNF-alpha levels were significantly higher in the CS than the AO with a significant positive correlation of the transcardiac gradient of TNF-alpha and the transcardiac gradient of oxLDL. Moreover, a significant negative correlation existed between the transcardiac gradient of oxLDL and left ventricular ejection fraction. The transcardiac gradient of plasma oxLDL was significantly lower in 6 patients who received carvedilol than in 16 patients who did not receive carvedilol. Conclusions These findings indicate that the transcardiac gradient of oxLDL may be a marker of oxidative stress in the heart and that left ventricular dysfunction may be partly due to the oxidative stress in patients with DCM. In addition, TNF-alpha may stimulate oxidative stress in the failing heart in patients with DCM. (J Am Coll Cardiol 2001;37:2086-92) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:2086 / 2092
页数:7
相关论文
共 34 条
[1]
BELCH JJF, 1991, BRIT HEART J, V65, P245
[2]
Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α [J].
Bryant, D ;
Becker, L ;
Richardson, J ;
Shelton, J ;
Franco, F ;
Peshock, R ;
Thompson, M ;
Giroir, B .
CIRCULATION, 1998, 97 (14) :1375-1381
[3]
Molecular and cellular mechanisms of myocardial failure [J].
Colucci, WS .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11A) :L15-L25
[4]
Angiotensin II and the heart - On the intracrine renin-angiotensin system [J].
De Mello, WC ;
Danser, AHJ .
HYPERTENSION, 2000, 35 (06) :1183-1188
[5]
Role of oxidative stress in transition of hypertrophy to heart failure [J].
Dhalla, AK ;
Hill, MF ;
Singal, PK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (02) :506-514
[6]
Increased malondialdehyde in peripheral blood of patients with congestive heart failure [J].
DiazVelez, CR ;
GarciaCastineiras, S ;
MendozaRamos, E ;
HernandezLopez, E .
AMERICAN HEART JOURNAL, 1996, 131 (01) :146-152
[7]
ANGIOTENSIN-II STIMULATES NADH AND NADPH OXIDASE ACTIVITY IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
GRIENDLING, KK ;
MINIERI, CA ;
OLLERENSHAW, JD ;
ALEXANDER, RW .
CIRCULATION RESEARCH, 1994, 74 (06) :1141-1148
[9]
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy [J].
Habib, FM ;
Springall, DR ;
Davies, GJ ;
Oakley, CM ;
Yacoub, MH ;
Polak, JM .
LANCET, 1996, 347 (9009) :1151-1155
[10]
Association of a G994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese [J].
Ichihara, S ;
Yamada, Y ;
Yokota, M .
CIRCULATION, 1998, 98 (18) :1881-1885